第194届ENMC国际研讨会。第三届ENMC外显子跳跃研讨会：迈向反义介导的外显子跳跃在杜氏肌营养不良症临床应用 2012年12月8 - 10日，荷兰纳尔登 - Suppr

Suppr

超能文献

194th ENMC international workshop. 3rd ENMC workshop on exon skipping: towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8-10 December 2012, Naarden, The Netherlands.

作者信息

Aartsma-Rus Annemieke, Muntoni Francesco

机构信息

Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

出版信息

Neuromuscul Disord. 2013 Nov;23(11):934-44. doi: 10.1016/j.nmd.2013.06.369. Epub 2013 Jul 24.

DOI:10.1016/j.nmd.2013.06.369

PMID:23890933

Abstract

摘要

相似文献

194th ENMC international workshop. 3rd ENMC workshop on exon skipping: towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8-10 December 2012, Naarden, The Netherlands.第194届ENMC国际研讨会。第三届ENMC外显子跳跃研讨会：迈向反义介导的外显子跳跃在杜氏肌营养不良症临床应用 2012年12月8 - 10日，荷兰纳尔登

Neuromuscul Disord. 2013 Nov;23(11):934-44. doi: 10.1016/j.nmd.2013.06.369. Epub 2013 Jul 24.

128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands.第128届ENMC国际研讨会：“杜氏肌营养不良症中使用反义寡核苷酸的临床前优化及I/II期临床试验”，2004年10月22日至24日，荷兰纳尔登

Neuromuscul Disord. 2005 Jun;15(6):450-7. doi: 10.1016/j.nmd.2005.02.007. Epub 2005 Apr 18.

Designing Effective Antisense Oligonucleotides for Exon Skipping.设计用于外显子跳跃的有效反义寡核苷酸

Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.

149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy".第149届欧洲神经肌肉疾病中心（ENMC）国际研讨会暨第一届杜氏肌营养不良症系统性递送反义寡核苷酸的I/II期临床试验规划TREAT-NMD研讨会

Neuromuscul Disord. 2008 Mar;18(3):268-75. doi: 10.1016/j.nmd.2007.11.010. Epub 2008 Jan 22.

Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy.寡核苷酸介导的外显子跳跃疗法治疗杜氏肌营养不良症的潜力。

Expert Opin Biol Ther. 2007 Jun;7(6):831-42. doi: 10.1517/14712598.7.6.831.

Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping.通过反义寡核苷酸介导的外显子跳跃实现精准医疗。

Trends Pharmacol Sci. 2018 Nov;39(11):982-994. doi: 10.1016/j.tips.2018.09.001. Epub 2018 Sep 30.

Less is more: therapeutic exon skipping for Duchenne muscular dystrophy.少即是多：杜氏肌营养不良症的治疗性外显子跳跃

Lancet Neurol. 2009 Oct;8(10):873-5. doi: 10.1016/S1474-4422(09)70229-7. Epub 2009 Aug 25.

Recent advancements in exon-skipping therapies using antisense oligonucleotides and genome editing for the treatment of various muscular dystrophies.最近在使用反义寡核苷酸和基因组编辑治疗各种肌营养不良症的外显子跳跃疗法方面取得了进展。

Expert Rev Mol Med. 2019 Oct 2;21:e5. doi: 10.1017/erm.2019.5.

Overview on DMD exon skipping.杜氏肌营养不良症外显子跳跃概述。

Methods Mol Biol. 2012;867:97-116. doi: 10.1007/978-1-61779-767-5_7.

[Advances of treatment for Duchenne muscular dystrophy with exon skipping].[杜氏肌营养不良症外显子跳跃治疗进展]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Aug;28(4):406-8. doi: 10.3760/cma.j.issn.1003-9406.2011.04.010.

引用本文的文献

Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease.行业指南草案：杜氏肌营养不良症、贝克肌营养不良症和相关肌营养不良症——为整个疾病谱开发潜在的治疗方法。

J Neuromuscul Dis. 2024;11(2):499-523. doi: 10.3233/JND-230219.

Systemic administration of the antisense oligonucleotide NS-089/NCNP-02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial.系统给予反义寡核苷酸 NS-089/NCNP-02 治疗杜氏肌营养不良症患者跳过外显子 44：一项 I/II 期临床试验的研究方案。

Neuropsychopharmacol Rep. 2023 Jun;43(2):277-286. doi: 10.1002/npr2.12335. Epub 2023 Apr 3.

Lifespan Analysis of Dystrophic Fast-Twitch Muscle Morphology and Its Impact on Contractile Function.营养不良性快肌形态的寿命分析及其对收缩功能的影响。

Front Physiol. 2021 Dec 7;12:771499. doi: 10.3389/fphys.2021.771499. eCollection 2021.

Loss of α-actinin-3 confers protection from eccentric contraction damage in fast-twitch EDL muscles from aged mdx dystrophic mice by reducing pathological fibre branching.丧失α-辅肌动蛋白-3 通过减少病理性纤维分支，为快速抽搐型 EDL 肌肉提供了对离心收缩损伤的保护，这种保护作用源自衰老 mdx 肌肉营养不良型小鼠。

Hum Mol Genet. 2022 May 4;31(9):1417-1429. doi: 10.1093/hmg/ddab326.

Genotype-Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry.来自加拿大神经肌肉疾病登记处的杜氏和贝克型肌营养不良症患者的基因型-表型相关性

J Pers Med. 2020 Nov 23;10(4):241. doi: 10.3390/jpm10040241.

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne.评价血清 MMP-9 作为杜氏肌营养不良症反义治疗的预测性生物标志物。

Sci Rep. 2017 Dec 20;7(1):17888. doi: 10.1038/s41598-017-17982-y.

GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells.通过外显子包含在诱导多能干细胞衍生的骨骼肌细胞中缓解庞贝病中的酸性α-葡萄糖苷酶缺乏症。

Mol Ther Nucleic Acids. 2017 Jun 16;7:101-115. doi: 10.1016/j.omtn.2017.03.002. Epub 2017 Mar 14.

Circulating Biomarkers for Duchenne Muscular Dystrophy.杜氏肌营养不良症的循环生物标志物

J Neuromuscul Dis. 2015 Jul 22;2(s2):S49-S58. doi: 10.3233/JND-150102.

Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy.深度RNA分析确定了CLOCK和分子时钟基因是VI型胶原肌病的病理生理特征。

J Cell Sci. 2016 Apr 15;129(8):1671-84. doi: 10.1242/jcs.175927. Epub 2016 Mar 4.

Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.肌营养不良蛋白的缺失会破坏骨骼肌信号传导：钙离子、活性氧和一氧化氮在肌肉萎缩症发展中的作用。

Physiol Rev. 2016 Jan;96(1):253-305. doi: 10.1152/physrev.00007.2015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验